Table 1.
Clinical characteristics of study subjects.
| Cohort | |
|---|---|
| n | 126 |
| Gender (% female) | 43.7 |
| Age (years) | 61.3 ± 8.7 |
| BMI | 29.8 ± 7.5 |
| Systolic BP (mmHg) | 116.1 ± 14.9 |
| Diastolic BP (mmHg) | 61.8 ± 10.7 |
| Statins (%) | 42.9 |
| Total cholesterol (mg/dL) | 180.4 ± 34.8 |
| LDL cholesterol (mg/dL) | 96 ± 31.9 |
| HDL cholesterol (mg/dL) | 58.3 ± 17.6 |
| Triglyceride (mg/dL) | 136.1 ± 95.4 |
| HDL particle number (μmol/L) | 35.2 ± 5.9 |
| HDL size (nm) | 9.4 ± 0.6 |
| LDL particle number (nmol/L) | 1183.8 ± 437.6 |
| LDL size (nm) | 20.5 ± 0.6 |
| VLDL particle number (nmol/L) | 62.3 ± 47.9 |
| VLDL size (nm) | 49.9 ± 7.4 |
| Calcified burden > 0 (%) | 69.8 |
| Calcified burden (Agatston score) | 281.3 ± 616.5 |
| Non-calcified burden (mm2) | 0.0109 ± 0.0042 |
Continuous variables are expressed as mean ± standard deviation.